Search Results: Displaying all items (77)

First Author Title Journal Publication Date
Walsh DS. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis. Vaccine 2016
Goebel KM. Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review. Communicable diseases intelligence quarterly report 2015
Danel C. Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PloS one 2014
Son CN. Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection. Journal of Korean medical science 2014
Seo KW. Persistently retained interferon-gamma responsiveness in individuals with a history of pulmonary tuberculosis. The Tohoku journal of experimental medicine 2014
Sauzullo I. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. The new microbiologica 2014
Shaik J. The role of interferon gamma release assays in the monitoring of response to anti-tuberculosis treatment in children. Paediatric respiratory reviews 2013
Woo KS. Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice. Clinica chimica acta; international journal of clinical chemistry 2014
Johnson JL. Effect of Isoniazid Therapy for Latent Tuberculosis Infection on QuantiFERON-TB Gold In-tube Responses in Tuberculin Skin Test Positive Adults in a High Tuberculosis Incidence Area: A Controlled Study. Chest 2013
Wang H. Clinical value of a whole blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection during antitubercular treatment. Experimental and therapeutic medicine 2013
Cordero-Coma M. Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes. Archivos de la Sociedad Espanola de Oftalmologia 2013
Kim CH. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment Immune responses in patients with active tuberculosis. Cytometry. Part B, Clinical cytometry 2013
Shu CC. Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study. The Journal of infection 2013
Aichelburg MC. Reversion and Conversion of Interferon-γ Release Assay Results in HIV-1-Infected Individuals. The Journal of infectious diseases 2013
Sauzullo I. IFN-γ release assay for tuberculosis in psoriasis patients treated with TNF antagonists: in vivo and in vitro analysis. The British journal of dermatology 2013
Drago L. Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy. Dermatology and therapy 2013
Kazama H. [Contact investigation using QuantiFERON-TB Gold test to evaluate TB exposure in 61 subjects in a hospital setting--(2) Change in QuantiFERON response during one year after exposure]. Kekkaku : [Tuberculosis] 2013
Bastos ML. Changes in QuantiFERON®-TB Gold In-Tube results during treatment for tuberculous infection. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013
Takenami I. Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting. Pulmonary medicine 2012
Chen YM. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection. Rheumatology (Oxford, England) 2012
Load More Results